Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Archifar is an Italian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), with a historical focus on beta-lactam antibiotics, particularly cephalosporins. Founded in 1966 and headquartered in Rovereto, Italy, the company provides contract manufacturing services and high-quality chemical synthesis for the global pharmaceutical industry. In 2007, Archifar was acquired by Gnosis S.p.A., which subsequently became part of the Lesaffre Group. Today, the Rovereto site continues to operate as a key manufacturing facility within the Gnosis by Lesaffre network, leveraging its expertise in complex chemical processes and GMP-compliant production. The facility is recognized for its adherence to international quality standards, including approvals from the FDA and other major regulatory bodies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Archifar.